IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 63 filers reported holding IGM BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $616,181 | -33.2% | 73,794 | -26.2% | 0.00% | – |
| Q2 2023 | $922,410 | -17.8% | 99,936 | +22.3% | 0.00% | – |
| Q1 2023 | $1,122,338 | -28.1% | 81,684 | -11.0% | 0.00% | – |
| Q4 2022 | $1,560,446 | -31.4% | 91,737 | -8.3% | 0.00% | – |
| Q3 2022 | $2,274,000 | +0.8% | 99,993 | -20.1% | 0.00% | – |
| Q2 2022 | $2,255,000 | -12.7% | 125,142 | +29.6% | 0.00% | – |
| Q1 2022 | $2,582,000 | +72.7% | 96,590 | +89.5% | 0.00% | – |
| Q4 2021 | $1,495,000 | -49.9% | 50,979 | +12.2% | 0.00% | – |
| Q3 2021 | $2,987,000 | -20.3% | 45,418 | +0.8% | 0.00% | – |
| Q2 2021 | $3,750,000 | +14.4% | 45,066 | +5.5% | 0.00% | – |
| Q1 2021 | $3,277,000 | +16.9% | 42,721 | +34.5% | 0.00% | – |
| Q4 2020 | $2,804,000 | +1391.5% | 31,763 | +1147.6% | 0.00% | – |
| Q3 2020 | $188,000 | -66.4% | 2,546 | -66.8% | 0.00% | – |
| Q2 2020 | $559,000 | +150.7% | 7,661 | +93.6% | 0.00% | – |
| Q1 2020 | $223,000 | -24.9% | 3,958 | -49.1% | 0.00% | – |
| Q4 2019 | $297,000 | +2021.4% | 7,770 | +910.4% | 0.00% | – |
| Q3 2019 | $14,000 | – | 769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |